Acinetobacter Infections in Neonates
Purpose of Review
MDR-Gram-negative bacteria are a great concern in the neonatal population, with a worldwide rise in the reported incidence and with very limited therapeutic options. Acinetobacter baumannii is responsible for many infections in neonates and outbreaks in neonatal intensive care unit (NICU); also, outbreaks caused by other Acinetobacter species have been reported. The aim of this review is to document the epidemiology of Acinetobacter spp. infections in neonates and risk factors for acquisition of Acinetobacter spp. in the NICU using data from published studies.
Acinetobacter spp. infections are increasing in neonates in NICU. Outbreak caused by multidrug resistant (MDR) or extensively drug resistant (XDR) A. baumannii but also outbreak caused by susceptible A. soli and A. septicus sp. nov., were reported in neonates. Acinetobacter spp. were responsible for bloodstream infections and respiratory tract infections in neonates. Risk factors for A. baumannii acquisition in neonates were low birthweight, length of NICU stay, umbilical catheterization, central-venous catheterization, assisted ventilation, and prior antibiotic use.
This review highlights the importance of surveillance of risk factors for healthcare-associated infections in NICU to control MDR and XDR A. baumannii infections in neonates.
KeywordsAcinetobacter Neonatal intensive care unit Outbreak Antimicrobial resistance Infection Risk factor analysis
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest relevant to this article.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.Marí-Almirall M, Cosgaya C, Higgins PG, Van Assche A, Telli M, Huys G, et al. MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species. Clin Microbiol Infect. 2017;23(3):210.e1–9. https://doi.org/10.1016/j.cmi.2016.11.020.CrossRefGoogle Scholar
- 5.Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. https://doi.org/10.1111/j.1469-0691.2011.03570.x.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Giannouli M, Antunes LC, Marchetti V, Triassi M, Visca P, Zarrilli R. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis. 2013;13:282. https://doi.org/10.1186/1471-2334-13-282.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.•• Al Jarousha AM, El Jadba AHN, Al Afifi AS, El Qouqa IA. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Int J Infect Dis. 2009;13(5):623–8. https://doi.org/10.1016/j.ijid.2008.08.029 This case-control study identifies for the first time risk factors for A. baumannii acquisition in NICU. CrossRefPubMedPubMedCentralGoogle Scholar
- 11.• Lee HY, Hsu SY, Hsu JF, Chen CL, Wang YH, Chiu CH. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates. J Microbiol Immunol Infect. 2018;51(3):367–76. https://doi.org/10.1016/j.jmii.2017.07.013 This is a large case series study on A. baumannii bacteremia in neonates. CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Touati A, Achour W, Cherif A, Hmida HB, Afif FB, Jabnoun S, et al. Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol. 2009;19(6):372–8. https://doi.org/10.1016/j.annepidem.2009.03.010.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.• Chatterjee S, Datta S, Roy S, Ramanan L, Saha A, Viswanathan R, et al. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to ISAba125. Front Microbiol. 2016;7:1126. https://doi.org/10.3389/fmicb.2016.01126 This study characterizes at molecular level MDR non-baumannii Acinetobacter isolates. CrossRefPubMedPubMedCentralGoogle Scholar
- 16.McGrath EJ, Chopra T, Abdel-Haq N, Preney K, Koo W, Asmar BI, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol. 2011;32(1):34–41. https://doi.org/10.1086/657669.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.•• Zarrilli R, Di Popolo A, Bagattini M, Giannouli M, Martino D, Barchitta M, et al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect. 2012;82(4):260–5. https://doi.org/10.1016/j.jhin.2012.08.018 This case-control study genotypes A. baumannii isolates, analyzes risk factors for A. baumannii acquisition and describes infection control measures for the containment of the outbreak. CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Tsiatsiou O, Iosifidis Ε, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, et al. Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Eur J Pediatr. 2015;174(1):65–74. https://doi.org/10.1007/s00431-014-2365-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.• Wei HM, Hsu YL, Lin HC, Hsieh TH, Yen TY, Lin HC, et al. Multidrug-resistant Acinetobacter baumannii infection among neonates in a neonatal intensive care unit at a medical center in central Taiwan. J Microbiol Immunol Infect. 2015;48(5):531–9. https://doi.org/10.1016/j.jmii.2014.08.025 This is a large case series study on A. baumannii bloodstream infections and respiratory infections in neonates. CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Yusef D, Shalakhti T, Awad S, Algharaibeh H, Khasawneh W. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review. Pediatr Neonatol. 2018;59(1):35–41. https://doi.org/10.1016/j.pedneo.2017.06.001.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.• Zimmerman P A, Lyman M, Andersson P. Acinetobacter baumannii outbreak in NICU at the Colonial War Memorial Hospital Suva, Fiji, December 2016–July 2017. Ministry of Health and Medical Services of Fiji-September 2017. Available at: http://www.health.gov.fj/wp-content/uploads/2017/09/ACINETOBACTER-BAUMANNII-JULY-2017.pdf. This is an outbreak investigation in which A. baumannii isolates were genotyped by whole genome sequencing.